---
schema_version: "secwatch.filing_event.v1"
accession: "0001773751-23-000204"
form_type: "8-K"
ticker: "HIMS"
cik: "0001773751"
company_name: "Hims & Hers Health, Inc."
filed_at: "2023-08-07T23:59:59+00:00"
generated_at: "2026-06-12T04:36:15.925719+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Hims & Hers Q2 revenue up 83% to $207.9M; raises FY 2023 guidance

## Summary
- Revenue $207.9M, up 83% YoY; net loss narrowed to $7.2M from $19.7M.
- Adjusted EBITDA turned positive at $10.6M versus -$7.5M in Q2 2022.
- Subscribers grew 74% to 1.3M; monthly online revenue per subscriber $53.
- Raised FY 2023 revenue guidance to $830-850M and Adjusted EBITDA to $35-40M.
- Expanded into Cardiovascular Health and Weight Management categories.

## SEC filing metadata
- accession: 0001773751-23-000204
- form_type: 8-K
- ticker: HIMS
- cik: 0001773751
- company_name: Hims & Hers Health, Inc.
- filed_at: 2023-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1773751/000177375123000204/0001773751-23-000204-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1773751/000177375123000204/hims-20230807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001773751-23-000204
- JSON: https://secwatch.observer/filing/0001773751-23-000204.json
- Plain text: https://secwatch.observer/filing/0001773751-23-000204.txt

## Key facts
- Earnings Releases
  Hims & Hers Health, Inc. reported the quarter ended June 30, 2023 results: revenue $207.9 million, net income $(7.2) million. Guidance raised.
  - Period: the quarter ended June 30, 2023
  - Revenue: $207.9 million
  - Net income: $(7.2) million
  - Guidance: raised
  - Result: reported results
  source text: reference in such a filing. --- EX-99.1 (EX-99.1) --- Hims & Hers Health, Inc. Reports Second Quarter 2023 Financial Results and Raises Full Year 2023 Outlook Revenue of $207.9 million, up 83% year-over-year in Q2 2023 Net loss of $7.2 million; Adjusted EBITDA profitability of $10.6 million in Q2 2023 Subscribers grew to 1.3 million, up 74% year-over-year in Q2
  evidence_url: https://www.sec.gov/Archives/edgar/data/1773751/000177375123000204/0001773751-23-000204-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.